H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma
Pathology - Research and Practice · 2023-02 · 242 · 154337
DOI: 10.1016/j.prp.2023.154337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023-02. Verfasst von Costantino Ricci und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, Maggiore Hospital-AUSL Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of …. Hauptthemen laut MEDLINE: Testicular Neoplasms, Seminoma, Carcinoma, Embryonal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Lymphovascular invasion (LVI) is a relevant prognostic factor in germ cell tumors of the testis (GCTT), and it is included in the pT stage. However, its detection on hematoxylin and eosin (H&E) slides is very challenging, and previous studies reported fair to moderate inter-observer agreement among dedicated uropathologists. In the present study, we tested H&E and a recently developed in-house double staining for OCT4/CD34 to detect LVI in GCTT. METHODS: Nine authors [5 non-uropathologists and 4 uropathologists] independently evaluated 34 consecutive and retrospectively enrolled cases of GCTT. We assessed the inter-observer agreement (Fleiss's Kappa) with both H&E and OCT4/CD34. Besides, we compared the consensus diagnosis on both H&E and OCT4/CD34-stained sections with the original diagnosis to evaluate the pT re-staging (McNemar test) and identify the sources of disagreement. RESULTS: The inter-observer agreement among uropathologists plus non-uropathologists was fair with both H&E (KF=0.398; p < 0.001) and OCT4/CD34 (KF=0.312; p < 0.001). OCT4/CD34 (KF=0.290; p < 0.001) slightly reduces the inter-observer agreement compared to H&E (KF=0.321; p < 0.001) for non-uropathologists; in contrast, OCT4/CD34 (KF=0.293; p < 0.001) significantly reduces the inter-observer agreement compared to H&E (KF=0.529; p < 0.001) for uropathologists, changing it from moderate to fair. Consensus diagnosis with H&E modified the LVI status of the original diagnosis in 8/34 (23.5 %) cases (p: 0.070), with pT re-staging in 2/34 (5.9 %) cases (p: 0.500). Consensus diagnosis with OCT4/CD34 modified the LVI status of the original diagnosis in 8/34 (23.5 %) cases (p: 0.289), with pT re-staging in 3/34 (8.8 %) cases (p: 0.250). The consensus diagnosis with OCT4/CD34 modified the consensus diagnosis with H&E in 8/34 (23.5 %) cases (p: 0.727), and these findings resulted in pT-restaging in 3/34 (8.8 %) cases (p: 0.500). The sources of disagreement among uropathologists were: H&E [artefactual clefts misinterpreted as LVI in 4/6 (66.7 %) cases and true foci of LVI misinterpreted as clusters of histiocytes within the vessels in 2/6 (33.3 %) cases], OCT4/CD34 [artefactual clefts misinterpreted as LVI in 2/8 (25 %) cases, true LVI misinterpreted as artefactual clefts in 2/8 (25 %) cases or floaters in 4/8 (50 %) cases]. CONCLUSIONS: OCT4/CD34 does not improve the inter-observer agreement for the assessment of LVI in OCT4(+) GCTT. Consensus diagnosis with H&E modifies the LVI status in a significant number of cases, resulting in changes of the pT stage in a relatively small subgroup. Consensus diagnosis with OCT4/CD34 provides little additional benefit since it cannot exclude mimickers of LVI such as floaters and artefactual clefts. These results argue against the adoption of this diagnostic tool for the routine assessment of OCT4(+) GCTT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, Maggiore Hospital-AUSL Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
- Pathology Unit, Maggiore Hospital-AUSL Bologna, Bologna, Italy.
- Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Urology Department, Maggiore Hospital-AUSL Bologna, Bologna, Italy.
- Department of Pathology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Zitieren
APA
Ricci, C., Ambrosi, F., Franceschini, T., Giunchi, F., Maracci, M. E., Sirolli, M., Orsatti, A., Chiarucci, F., Franchini, E., Borsato, M., Massari, F., Mollica, V., Bianchi, F. M., Colecchia, M., Acosta, A. M., & Fiorentino, M. (2023). H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma. Pathology - Research and Practice, 242, 154337. https://doi.org/10.1016/j.prp.2023.154337
Vancouver
Ricci C, Ambrosi F, Franceschini T, Giunchi F, Maracci ME, Sirolli M, et al. H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma. Pathology - Research and Practice. 2023;242:154337. doi:10.1016/j.prp.2023.154337
BibTeX
@article{Ricci2023,
author = {Ricci, Costantino and Ambrosi, Francesca and Franceschini, Tania and Giunchi, Francesca and Maracci, Maria Eugenia and Sirolli, Maria and Orsatti, Agnese and Chiarucci, Federico and Franchini, Eugenia and Borsato, Matteo and Massari, Francesco and Mollica, Veronica and Bianchi, Federico Mineo and Colecchia, Maurizio and Acosta, Andres Martin and Fiorentino, Michelangelo},
title = {H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma},
journal = {Pathology - Research and Practice},
year = {2023},
volume = {242},
pages = {154337},
doi = {10.1016/j.prp.2023.154337}
}
EUVIMED